BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 17306025)

  • 41. Nuclear bodies and compartments: functional roles and cellular signalling in health and disease.
    Zimber A; Nguyen QD; Gespach C
    Cell Signal; 2004 Oct; 16(10):1085-104. PubMed ID: 15240004
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The HTLV-1 HBZ protein inhibits cyclin D1 expression through interacting with the cellular transcription factor CREB.
    Ma Y; Zheng S; Wang Y; Zang W; Li M; Wang N; Li P; Jin J; Dong Z; Zhao G
    Mol Biol Rep; 2013 Oct; 40(10):5967-75. PubMed ID: 24065533
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Heterodimerization with different Jun proteins controls c-Fos intranuclear dynamics and distribution.
    Malnou CE; Brockly F; Favard C; Moquet-Torcy G; Piechaczyk M; Jariel-Encontre I
    J Biol Chem; 2010 Feb; 285(9):6552-62. PubMed ID: 20053986
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [HTLV-1 pathogenesis mediated by HTLV-1 bZIP factor].
    Satou Y
    Uirusu; 2012 Jun; 62(1):113-20. PubMed ID: 23189831
    [TBL] [Abstract][Full Text] [Related]  

  • 45. HTLV-1 HBZ protein deregulates interactions between cellular factors and the KIX domain of p300/CBP.
    Cook PR; Polakowski N; Lemasson I
    J Mol Biol; 2011 Jun; 409(3):384-98. PubMed ID: 21497608
    [TBL] [Abstract][Full Text] [Related]  

  • 46. HBZ is an immunogenic protein, but not a target antigen for human T-cell leukemia virus type 1-specific cytotoxic T lymphocytes.
    Suemori K; Fujiwara H; Ochi T; Ogawa T; Matsuoka M; Matsumoto T; Mesnard JM; Yasukawa M
    J Gen Virol; 2009 Aug; 90(Pt 8):1806-1811. PubMed ID: 19423550
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Dual effects of HTLV-1 bZIP factor in suppression of interferon regulatory factor 1.
    Mukai R; Ohshima T
    Biochem Biophys Res Commun; 2011 Jun; 409(2):328-32. PubMed ID: 21586271
    [TBL] [Abstract][Full Text] [Related]  

  • 48. HTLV-1 bZIP factor protein targets the Rb/E2F-1 pathway to promote proliferation and apoptosis of primary CD4(+) T cells.
    Kawatsuki A; Yasunaga JI; Mitobe Y; Green PL; Matsuoka M
    Oncogene; 2016 Aug; 35(34):4509-17. PubMed ID: 26804169
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Non-canonical translation initiation of the spliced mRNA encoding the human T-cell leukemia virus type 1 basic leucine zipper protein.
    Cáceres CJ; Angulo J; Lowy F; Contreras N; Walters B; Olivares E; Allouche D; Merviel A; Pino K; Sargueil B; Thompson SR; López-Lastra M
    Nucleic Acids Res; 2018 Nov; 46(20):11030-11047. PubMed ID: 30215750
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Inhibition of the hTERT promoter by the proto-oncogenic protein TAL1.
    Terme JM; Mocquet V; Kuhlmann AS; Zane L; Mortreux F; Wattel E; Duc Dodon M; Jalinot P
    Leukemia; 2009 Nov; 23(11):2081-9. PubMed ID: 19587703
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [HTLV-1 bZIP Factor (HBZ) gene has a growth-promoting effect on adult T-cell leukemia cells].
    Satou Y; Yasunaga J; Yoshida M; Matsuoka M
    Rinsho Ketsueki; 2008 Nov; 49(11):1525-9. PubMed ID: 19047782
    [No Abstract]   [Full Text] [Related]  

  • 52. Impact of the SCF signaling pathway on leukemia stem cell-mediated ATL initiation and progression in an HBZ transgenic mouse model.
    Kuribayashi W; Takizawa K; Sugata K; Kuramitsu M; Momose H; Sasaki E; Hiradate Y; Furuhata K; Asada Y; Iwama A; Matsuoka M; Mizukami T; Hamaguchi I
    Oncotarget; 2016 Aug; 7(32):51027-51043. PubMed ID: 27340921
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The splice 1 variant of HTLV-1 bZIP factor stabilizes c-Jun.
    Polakowski N; Pearce M; Kuguyo O; Boateng G; Hoang K; Lemasson I
    Virology; 2020 Oct; 549():51-58. PubMed ID: 32841759
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Development of T cell lymphoma in HTLV-1 bZIP factor and Tax double transgenic mice.
    Zhao T; Satou Y; Matsuoka M
    Arch Virol; 2014 Jul; 159(7):1849-56. PubMed ID: 24818712
    [TBL] [Abstract][Full Text] [Related]  

  • 55. HBZ upregulates myoferlin expression to facilitate HTLV-1 infection.
    Polakowski N; Sarker MAK; Hoang K; Boateng G; Rushing AW; Kendle W; Pique C; Green PL; Panfil AR; Lemasson I
    PLoS Pathog; 2023 Feb; 19(2):e1011202. PubMed ID: 36827461
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The HTLV-1-encoded protein HBZ directly inhibits the acetyl transferase activity of p300/CBP.
    Wurm T; Wright DG; Polakowski N; Mesnard JM; Lemasson I
    Nucleic Acids Res; 2012 Jul; 40(13):5910-25. PubMed ID: 22434882
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Recent progress in ATL and HTLV-1 research].
    Matsuoka M
    Rinsho Ketsueki; 2008 Oct; 49(10):1508-14. PubMed ID: 18833935
    [No Abstract]   [Full Text] [Related]  

  • 58. c-Myc localization within the nucleus: evidence for association with the PML nuclear body.
    Smith KP; Byron M; O'Connell BC; Tam R; Schorl C; Guney I; Hall LL; Agrawal P; Sedivy JM; Lawrence JB
    J Cell Biochem; 2004 Dec; 93(6):1282-96. PubMed ID: 15503302
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Does the HBZ gene represent a new potential target for the treatment of adult T-cell leukemia?
    Barbeau B; Mesnard JM
    Int Rev Immunol; 2007; 26(5-6):283-304. PubMed ID: 18027202
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Molecular pathogenesis by human T-cell leukemia virus type 1].
    Matsuoka M
    Rinsho Ketsueki; 2011 May; 52(5):256-62. PubMed ID: 21646770
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.